Optimizing T cell expansion in vitro for cancer immunotherapy

$226
Raised of $10,400 Goal
3%
Ended on 2/21/23
Campaign Ended
  • $226
    pledged
  • 3%
    funded
  • Finished
    on 2/21/23

Lab Notes